Image of several groups of people
HHS Office of Inspector General
 

Hearing Testimony

 Hearing Testimony
  
 

Current Year's Testimony

Previous Years

   
 
Hearing Testimony
    

2008

 

 

07/09/08

Testimony of Robert Vito, Regional Inspector General for Evaluation and Inspections, Office of Inspector General, U.S. Department of Health and Human Services, before the U.S. Senate Permanent Subcommittee on Investigations, Committee on Homeland Security and Governmental Affairs PDF

05/15/08

Testimony of Lewis Morris, Chief Counsel to the Inspector General, before the U.S. House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations, on Nursing Home Quality Issues PDF

02/27/08

Testimony of Gregory Demske, Assistant Inspector General for Legal Affairs, before the U.S. Senate Special Committee on Aging Examining the Relationship between the Medical Device Industry and Physicians PDF

2007

 

 

07/18/07

Statement of Gregory Demske, Assistant Inspector General for Legal Affairs, before the U.S. Senate Special Committee on Aging on the Role of OIG in Identifying and Preventing the Abuse of the Elderly PDF

06/26/07

Testimony of Robert A. Vito, Regional Inspector General for Evaluation and Inspections Office of Inspector General, U.S. Department of Health and Human Services, before the House Committee on Ways and Means Subcommittee on Health on ESRD-Related Services PDF

04/18/07

Testimony of Stuart Wright, Deputy Inspector General for Evaluation and Inspections, before the Subcommittee on Health of the U.S. House Committee on Energy and Commerce on Medicare Program Efficiency and Integrity PDF

03/08/07

Testimony of Daniel R. Levinson, Inspector General, before the U.S. House of Representatives Ways and Means Subcommittees on Health and Oversight on Medicare Program Integrity PDF

02/09/07

 Testimony of Lewis Morris, Chief Counsel to the Inspector General, before the U.S. House Oversight and Government Reform Committee, on Allegations of Waste, Fraud and Abuse in Pharmaceutical Pricing: Financial Impacts on Federal Health Programs PDF

2006

 

 

07/13/06

 Testimony of Robert A. Vito, Regional Inspector General for Evaluation and Inspections, Philadelphia, before the House Committee on Ways & Means, Subcommittee on Health, on Medicare Part B Prescription Drug Reimbursements. PDF

04/06/06

 Testimony of Lewis Morris, Chief Counsel to the Inspector General, before the Subcommittee on Health of the U.S. House Committee on Ways and Means on issues regarding health care information technology PDF

03/28/06

 Testimony of Daniel R. Levinson, Inspector General, before the Subcommittee on Federal Financial Management, Government Information, and International Security of the Senate Committee on Homeland Security and Governmental Affairs on Medicaid Program Integrity PDF

2005

 

 

12/15/05

 Testimony of Stuart Wright, Deputy Inspector General for Evaluation and Inspections, before the Subcommittee on Oversight and Investigations of the U.S. House Committee on Energy and Commerce on 340B Drug Pricing Program Oversight and Administration PDF

10/07/05

 Testimony of Lewis Morris, Chief Counsel to the Inspector General, before the Subcommittee on Health of the U.S. House Committee on Ways and Means on Gainsharing Arrangements PDF

09/28/05

 Testimony of Joseph E. Vengrin, Deputy Inspector General for Audit Services and Michael E. Little, Deputy Inspector General for Investigations, before the Oversight and Investigations Subcommittee of the U.S. House Committee on Energy and Commerce on Guarding Against Waste, Fraud, and Abuse in Post-Katrina Relief and Recovery PDF

06/29/05

 Testimony of Robert A. Vito, Regional Inspector General for Evaluation and Inspections, Philadelphia, before the U.S. Senate Committee on Finance on Medicaid Payments for Prescription Drugs PDF

06/28/05

 Testimony of Daniel R. Levinson, Inspector General, before the U.S. Senate Committee on Finance on Medicaid: Federal and State Oversight PDF

06/28/05

Testimony of George M. Reeb, Assistant Inspector General for CMS Audits, before the U.S. Senate Committee on Finance on Medicaid: Financial Mechanisms to Shift Costs to the Federal Government PDF

02/17/05

Testimony of Daniel R. Levinson, Acting Inspector General, before the U.S. Senate Committee on Finance on Confirmation PDF

2004

 

 

12/07/04

Testimony of George Reeb, Assistant Inspector General for CMS Audits, before the Oversight and Investigations Subcommittee of the U.S. House Committee on Energy and Commerce on Medicaid-Covered Drugs and Why the Government Pays Too Much PDF

06/24/04

Testimony of Lewis Morris, Chief Counsel to the Inspector General, before the Oversight and Investigations Subcommittee of the U.S. House Committee on Energy and Commerce on Discounts Offered to Patients Who Cannot Afford to Pay Their Hospital Bills PDF

04/28/04

Testimony of Dara Corrigan, Acting Principal Deputy Inspector General, before the U.S. Senate Committee on Finance on Medicare Reimbursement for Power Wheelchairs PDF

03/18/04

Testimony of George Reeb, Assistant Inspector General for CMS Audits, before the House Energy and Commerce Subcommittee on Health on Intergovernmental Transfers and Accountability of Medicaid Funds PDF

2003

 

 

07/17/03

Testimony of Dara Corrigan, Acting Principal Deputy Inspector General, before the U.S. Senate Committee on Finance on the Quality of Care in Nursing Homes Nationwide PDF

07/09/03

Testimony of Dara Corrigan, Acting Principal Deputy Inspector General, before the U.S. House of Representatives Committee on the Budget on Fraud, Waste and Abuse in the Medicare and Medicaid Programs PDF

2002

 

 

10/03/02

Testimony of George Reeb, Assistant Inspector General, before the House Committee on Ways and Means, Subcommittee on Health on Medicare Payments for Currently Covered Prescription Drugs PDF

07/31/02

Testimony of Michael F. Mangano, Principal Deputy Inspector General, before the Senate Committee on Governmental Affairs, Subcommittee on Oversight of Government Management, Restructuring and the District of Columbia on consumer safety and the effectiveness of the Food and Drug Administration’s (FDA) adverse event reporting system for dietary supplements PDF

06/13/02

Testimony of Michael F. Mangano, Principal Deputy Inspector General, before the House Committee on Government Reform, Subcommittee on Government Efficiency, Financial Management and Intergovernmental Relations on how the Federal Government and the States protect the Medicaid program and its beneficiaries against fraud, waste, and abuse PDF

06/12/02

Testimony of Janet Rehnquist, Inspector General, before the Senate Committee on Appropriations Subcommittee on Labor, HHS, and Education on Medicare Reimbursement for Medical Equipment and Supplies PDF

05/01/02

Testimony of Janet Rehnquist, Inspector General, before the House Energy and Commerce, Oversight and Investigations Subcommittee on the "Oversight and Management of the Government Purchase Card Program" PDF

03/14/02

Testimony of Janet Rehnquist, Inspector General, before the Senate Committee on Finance on Medicare: Reimbursement for Prescription Drugs PDF

03/05/02

Testimony of Janet Rehnquist, Inspector General, before the House Subcommittee on Labor-HHS-Education Appropriations on the Office of Inspector General FY 2003 Budget PDF

 

 

 

Go to the top of the page
 
 
Link to Authorities & Federal Register Notices
Link to Publications
Link to Reports
Link to Hearing Testimony
Link to Fraud Prevention & Detection
Link to Reading Room
Link to Organization
Link to Employment Opportunities
 
Back to Previous page Link to Home page
 
 
 

E-Mail List | HIPDB | Hotline | Privacy Notice | Disclaimers
FOIA Information | Contact Us | What's New | Exclusions Database
HHS Homepage | IGnet | USA.gov | Accessibility | Adobe Acrobat

 
Go to the top of the page